Clinical trial
Evaluation of the Efficacy of Recombinant Human Brain Natriuretic Peptide in Patients With Diuretic Resistance After Cardiac Surgery: a Prospective Single-center Single-blind Randomized Controlled Study
NCT07086287 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Anhui Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Recombinant Human Brain Natriuretic Peptide in Patients With Diuretic Resistance After Cardiac Surgery: a Prospective Single-center Single-blind Randomized Controlled Study
- Lead sponsor
- The First Affiliated Hospital of Anhui Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2025
- Completion date
- June 30, 2028
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
after cardiac surgery, diuretic resistance